Baxter International Inc (BAX)
35.87
+0.17
(+0.48%)
USD |
NYSE |
Nov 01, 16:00
35.87
0.00 (0.00%)
After-Hours: 20:00
Baxter International Enterprise Value: 29.17B for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 29.17B |
| October 31, 2024 | 29.09B |
| October 30, 2024 | 29.17B |
| October 29, 2024 | 29.24B |
| October 28, 2024 | 29.25B |
| October 25, 2024 | 29.23B |
| October 24, 2024 | 29.61B |
| October 23, 2024 | 29.48B |
| October 22, 2024 | 29.54B |
| October 21, 2024 | 29.53B |
| October 18, 2024 | 29.68B |
| October 17, 2024 | 29.57B |
| October 16, 2024 | 29.63B |
| October 15, 2024 | 29.57B |
| October 14, 2024 | 29.70B |
| October 11, 2024 | 29.52B |
| October 10, 2024 | 29.77B |
| October 09, 2024 | 30.18B |
| October 08, 2024 | 29.81B |
| October 07, 2024 | 29.12B |
| October 04, 2024 | 29.40B |
| October 03, 2024 | 28.77B |
| October 02, 2024 | 29.23B |
| October 01, 2024 | 29.70B |
| September 30, 2024 | 30.25B |
| Date | Value |
|---|---|
| September 27, 2024 | 30.73B |
| September 26, 2024 | 30.62B |
| September 25, 2024 | 30.43B |
| September 24, 2024 | 30.76B |
| September 23, 2024 | 30.77B |
| September 20, 2024 | 30.51B |
| September 19, 2024 | 30.65B |
| September 18, 2024 | 30.96B |
| September 17, 2024 | 31.18B |
| September 16, 2024 | 31.41B |
| September 13, 2024 | 31.14B |
| September 12, 2024 | 30.96B |
| September 11, 2024 | 30.91B |
| September 10, 2024 | 30.88B |
| September 09, 2024 | 30.89B |
| September 06, 2024 | 30.75B |
| September 05, 2024 | 30.68B |
| September 04, 2024 | 30.02B |
| September 03, 2024 | 30.18B |
| August 30, 2024 | 30.23B |
| August 29, 2024 | 30.34B |
| August 28, 2024 | 30.17B |
| August 27, 2024 | 30.21B |
| August 26, 2024 | 30.23B |
| August 23, 2024 | 30.03B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
26.86B
Minimum
Oct 12 2023
59.68B
Maximum
Feb 09 2022
40.77B
Average
42.43B
Median
Dec 14 2020
Enterprise Value Benchmarks
| Boston Scientific Corp | 131.03B |
| Haemonetics Corp | 4.537B |
| Accuray Inc | 279.05M |
| Masimo Corp | 8.324B |
| Insulet Corp | 17.10B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -314.00M |
| Revenue (Quarterly) | 3.812B |
| Total Expenses (Quarterly) | 3.575B |
| EPS Diluted (Quarterly) | -0.62 |
| Gross Profit Margin (Quarterly) | 37.54% |
| Profit Margin (Quarterly) | -8.24% |
| Earnings Yield | 13.55% |
| Operating Earnings Yield | 3.81% |
| Normalized Earnings Yield | 1.174 |